Admin Core

由Richard Wyatt博士领导的行政核心A将管理对项目1和2以及核心B的支持 C，在这项新的HIVRAD提案的保护伞下。这一核心将协调行政伙伴关系 计划在HIVRAD工作组内部和相关外部研究人员之间保持良好的沟通， 与新型非切割非切割三聚体的设计和B细胞分析相关的顾问和利益相关者 这些HIV来源的包膜糖蛋白(Env)定时器免疫非人类所产生的应答 灵长类(NHP)。行政核心将建立HIVRAD网站和云数据存储 所有组件PI或/和指定人员均可访问。一个主要的科学目标，引出和定义第二级交叉 接种新的环境三聚体后，NHP中和B细胞和抗体反应(BNAbs)将是 由核心A转发。核心A的宗旨体现在以下任务的成功竞争上。 我们将进行项目管理，同时实施已制定的计划，以确保总体上的成功 P01方案。这一方法将由计划主任完成，并通过真实世界的学习得到加强 已完成的上一次Wyatt.Scripps HIVRAD中的流程。在项目2中，核心A将促进研究 更好地定义表达的NHP重链和轻链谱系以确定谱系和体细胞水平 异源三聚体引发的超突变：加强NHP免疫。我们将审查答复 由新的未切割的近天然NFL三聚体在功能和结构细节上引发的鉴定中和 用于基因分析的ABS。我们将使用NGS分析来跟踪抗体谱系来定义亲和力成熟，以及 调查抗体是否保存在长期存放室(骨髓)中。我们将应用深度测序 疫苗诱导的Env特异性B细胞反应的计算分析以确定表位特异性群体 NHP中的ABS。我们将研究免疫后Env特异性抗体谱系的演变 IGDiscover中基于NGS的跟踪模块。我们将定义单抗的成熟途径，并使用 重新设计三聚体免疫原的信息，以推动反应朝着广泛的中和方向发展。我们将使用 环境病毒特异性血清抗体(核心C)的结构分析，以及从疫苗接种的NHP中分离的单抗(项目2) 迭代三聚体重新设计。HIVRAD研究团队将利用我们之前的发现来推动该领域的 了解疫苗诱导的B细胞对HIV-1中和决定簇的反应 NHP达到了以前无法接近的水平。新型B细胞分选探针(有序)的研究进展 切割不依赖的，avi标记的NFL三聚体)，克隆方法的进展，抗体表达，B细胞生发 NGS的中枢和淋巴结分析能力、抗体种系基因鉴定和抗体谱系追踪 让这成为一个非常及时和重要的应用。在这个新的应用程序中，我们将继续“移动栏” 利用新型共价颗粒显示器亚基环境疫苗诱导BABS的研究进展 以及在细胞表面拴系的NFL三聚体的脂质纳米颗粒mRNA表达方面令人兴奋的最新进展。

The Administrative Core A, led by Dr. Richard Wyatt, will administer support for Projects 1 and 2 and Cores B and C, under the umbrella of this new HIVRAD proposal. This Core will coordinate an administrative partnership plan to maintain good communications within the HIVRAD working group and relevant external researchers, advisors and stakeholders related to design of novel cleavage-independent trimers and the analysis of B cell responses generated by vaccination of these HIV-derived envelope glycoprotein (Env) timers into non-human primates (NHPs). The Administrative Core will establish a HIVRAD website as well as cloud data storage accessible to all component PIs or/and designates. A major scientific objective, to elicit and define tier 2 cross- neutralizing B cell and antibody responses (bNAbs) in NHPs following vaccination of novel Env trimers, will be forwarded by Core A. The purpose of Core A is embodied by the successful competition of the following tasks. We will perform project management, while implementing a developed plan to ensure the success of the overall P01 program. This approach will be accomplished by the Program Director, enhanced by real-world learning processes in the accomplished previous Wyatt.Scripps HIVRAD. In Project 2, the Core A will foster studies to better define the expressed NHP heavy and light chain repertoire to determine lineages and the levels of somatic hypermutation elicited by heterologous trimer prime:boost immunization in NHPs. We will examine responses elicited by the novel uncleaved near-native NFL trimers in functional and structural detail to identify neutralizing Abs for genetic analysis. We will use NGS analysis to follow Ab lineages to define affinity maturation, as well as to investigate if the Abs are archived in long-lived compartments (bone marrow). We will apply deep sequencing computational analysis of vaccine-induced Env-specific B cell responses to define populations of epitope-specific Abs in NHPs. We will investigate the evolution of Env-specific Ab lineages following immunization using the NGS-based tracing module within IgDiscover. We will define the maturation pathways of mAbs and use this information to re-design trimer immunogens to drive the responses in broadly neutralizing directions. We will use structural analysis of Env-specific serum Abs (Core C), and isolated mAbs from vaccinated NHPs (Project 2) for iterative trimer redesign. The HIVRAD research team will leverage our previous finding to advances the field's understanding of vaccine-elicited B cell responses to neutralizing determinants of HIV-1 in small animals and NHPs to a level not previously approachable. The continued development of novel B cell sorting probes (ordered cleavage-independent, Avi-tagged NFL trimers), advances in cloning methods, Ab expression, B cell germinal center and lymph node analytical capacities, Ab germline gene identification and Ab lineage tracing through NGS make this an extremely timely and important application. In this new application we will continue “move the bar” forward towards the elicitation of bAbs by subunit Env vaccination using novel, covalent particulate display as well as the exciting recent advances in lipid nanoparticle mRNA expression of cell-surface tethered NFL trimers.